Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10064934 Combination PIV3/hMPV RNA vaccines

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
August 11, 2017
Date of Patent
September 4, 2018
Patent Application Number
15674599
Patent Citations Received
‌
US Patent 12133899 Coronavirus vaccine
0
‌
US Patent 11484590 Human cytomegalovirus RNA vaccines
‌
US Patent 11485960 RNA polymerase variants for co-transcriptional capping
‌
US Patent 11497807 Zoonotic disease RNA vaccines
‌
US Patent 12109257 Alphavirus neoantigen vectors
0
‌
US Patent 12128113 Polynucleotides encoding JAGGED1 for the treatment of Alagille syndrome
0
‌
US Patent 11464848 Respiratory syncytial virus vaccine
‌
US Patent 10207010 Compositions and methods for delivery of agents
‌
US Patent 10272150 Combination PIV3/hMPV RNA vaccines
‌
US Patent 10273269 High potency immunogenic zika virus compositions
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10064934
Patent Primary Examiner
‌
Nicole Kinsey White

Find more entities like US Patent 10064934 Combination PIV3/hMPV RNA vaccines

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.